CompletedNot Applicable

Effect of Digital Follow-up Supported Patient Education on Immunosuppressive Medication Adherence and Quality of Life After Liver Transplantation

Turkey (Türkiye)48 participantsStarted 2026-01-23

Plain-language summary

This randomized controlled study aimed to evaluate the effect of digital follow-up supported patient education on immunosuppressive medication adherence and quality of life in adult liver transplant recipients. Participants in both groups received standard discharge education. The intervention group additionally received structured digital follow-up messages for 12 weeks, while the control group received standard care only. Medication adherence and quality of life were assessed before and after the intervention using validated questionnaires.

Who can participate

Age range

18 Years – 100 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 18 years or older. * Having undergone liver transplantation. * Currently receiving immunosuppressive therapy after liver transplantation. * Ability to read and write in Turkish. * Ability to use a smartphone to receive and follow digital messages. * Willingness to participate voluntarily in the study. * Provision of written informed consent. Exclusion Criteria: * Experiencing an acute rejection episode during the study period. * Presence of cognitive, psychiatric, or communication problems that would interfere with participation in the study. * Inability to regularly follow digital messages. * Difficulty reading and understanding Turkish. * Inability to maintain communication throughout the study period. * Refusal to participate in the study.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Immunosuppressive Medication Adherence

Timeframe: Baseline and 12 weeks

Trial details

NCT IDNCT07728604

SponsorCansu Yıldız

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-06-20

View on ClinicalTrials.gov More Liver Transplantation trials